CompletedNot Applicable

Neuromodulation of the Dorsal Genital Nerve in Persistent Genital Arousal Disorder

Netherlands12 participantsStarted 2023-04-26

Plain-language summary

The goal of this clinical trial is to learn if neuromodulation of the dorsal genital nerve works to treat symptoms related to Persistent Genital Arousal Disorder in women. The main questions it aims to answer are: What is the effect of neuromodulation on PGAD symptoms in women? Participants will: Use a neurosimulator every day for 3 weeks. Keep a diary of their symptoms and the number of times they used the neurostimulator Fill in questionaires

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with PGAD Exclusion Criteria: * Women \< 18 years * Women not able to handle the neuromodulator * Women in whom the anatomy of the genitals precludes proper electrode placement

What they're measuring

Symptom severity

Timeframe: 8 weeks

Neuromodulation effect

Timeframe: 3 weeks

Satisfaction device

Timeframe: At the end of the treatment, at week 8

Trial details

NCT IDNCT06790563

SponsorRadboud University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-20

View on ClinicalTrials.gov More Arousal Disorders, Sexual trials